Smith+Nephew is pioneering Spatial Surgery – a defining new Sports Medicine category pushing the boundaries of technology and procedural innovation

Core Insights - Smith+Nephew is pioneering technology in Spatial Surgery, aiming to enhance arthroscopic surgical innovation through personalized planning, augmented reality, and real-time data processing [1][4] - The company has submitted a traditional 510(k) application to the FDA for the TESSA Spatial Surgery System, which utilizes NVIDIA GPU technology for real-time tracking and augmented reality guidance during ACL reconstruction [2][3] - TESSA aims to reduce technical errors in ACL reconstruction, which are significant contributors to surgical failure, by improving operative planning and execution [3] Company Overview - Smith+Nephew is a global medical technology company focused on the repair, regeneration, and replacement of soft and hard tissue, with a mission to restore patients' bodies and self-belief [7] - The company operates in approximately 100 countries and reported annual sales of $5.8 billion in 2024, making it a constituent of the FTSE100 [8]